The coronavirus pandemic ushered in a new era of public scrutiny for the pharmaceutical industry. The general population was traditionally most invested in novel medicines in clinical trials – news reports and medical journal articles about new, promising drugs would make headlines, especially when they looked to treat afflictions that had few readily available treatment […]
The post Vaccine Safety in the Public Eye: How COVID-19 Brought Pharmacovigilance Center-Stage appeared first on ArisGlobal.